• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他克莫司联合强化局部结肠内给药治疗难治性溃疡性结肠炎1例

[A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].

作者信息

Matsumoto Ayako, Yajima Hiroyuki, Murata Tomoya, Gotou Kousuke, Okamoto Kenta, Nishiyama Hitoshi

机构信息

Department of Gastroenterology, National Hospital Organization Nagasaki Medical Center.

出版信息

Nihon Shokakibyo Gakkai Zasshi. 2013 Apr;110(4):639-47.

PMID:23558127
Abstract

A 30-year-old woman was referred to our hospital with recurrent refractory ulcerative colitis. She also suffered from avascular necrosis of the left femoral head caused by steroid use. We had expected that tacrolimus would contribute to remission, but effects remained insufficient even after 16 days of treatment. Intensive leukocytapheresis (LCAP) therapy was added to tacrolimus therapy, and this combination achieved remission. Tacrolimus plus intensive LCAP combination therapy appears useful in treating refractory ulcerative colitis.

摘要

一名30岁女性因复发性难治性溃疡性结肠炎转诊至我院。她还因使用类固醇导致左侧股骨头缺血性坏死。我们曾期望他克莫司能有助于病情缓解,但治疗16天后效果仍不充分。在他克莫司治疗基础上加用强化白细胞去除术(LCAP)治疗,这种联合治疗实现了病情缓解。他克莫司加强化LCAP联合治疗似乎对治疗难治性溃疡性结肠炎有效。

相似文献

1
[A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].他克莫司联合强化局部结肠内给药治疗难治性溃疡性结肠炎1例
Nihon Shokakibyo Gakkai Zasshi. 2013 Apr;110(4):639-47.
2
Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.他克莫司对一名白细胞去除术联合大剂量皮质类固醇治疗无效的重度溃疡性结肠炎患者的挽救治疗。
Intern Med. 2007;46(11):717-20. doi: 10.2169/internalmedicine.46.6219. Epub 2007 Jun 1.
3
Tacrolimus in corticosteroid-resistant ulcerative colitis.他克莫司用于皮质类固醇抵抗性溃疡性结肠炎
J Gastroenterol. 2000;35(8):635-40. doi: 10.1007/s005350070065.
4
Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.单因素分析以检查溃疡性结肠炎患者对白细胞去除术反应的预测因素。
Ther Apher Dial. 2014 Jun;18(3):244-51. doi: 10.1111/1744-9987.12211.
5
A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.白细胞吸附治疗后 1 年溃疡性结肠炎复发的临床结局和危险因素的多中心、回顾性、观察性研究。
J Gastroenterol. 2018 Mar;53(3):387-396. doi: 10.1007/s00535-017-1356-8. Epub 2017 Jun 8.
6
Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.他克莫司在住院的类固醇难治性急性重度溃疡性结肠炎患者中的疗效。
World J Gastroenterol. 2019 Apr 7;25(13):1603-1617. doi: 10.3748/wjg.v25.i13.1603.
7
Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.白细胞去除术(LCAP)用于慢性活动性溃疡性结肠炎的治疗——一项随机试点试验的结果
Dig Dis Sci. 2007 Sep;52(9):2044-53. doi: 10.1007/s10620-006-9696-x. Epub 2007 Apr 5.
8
A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.一项关于溃疡性结肠炎白细胞去除术的大规模、前瞻性观察性研究:847例临床实践患者的治疗结果
J Crohns Colitis. 2014 Sep;8(9):981-91. doi: 10.1016/j.crohns.2014.01.027. Epub 2014 Feb 18.
9
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.白细胞去除柱治疗溃疡性结肠炎的多中心随机对照试验
Curr Pharm Des. 2003;9(4):307-21. doi: 10.2174/1381612033391928.
10
LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.白细胞去除术在重度激素依赖型溃疡性结肠炎治疗中的应用
Acta Clin Croat. 2019 Sep;58(3):529-534. doi: 10.20471/acc.2019.58.03.18.